Clincosm LogoSign in Get a demo

hereditary angioedema

Showing 1 - 25 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hereditary Angioedema Trial (STAR-0215)

Not yet recruiting
  • Hereditary Angioedema
  • (no location specified)
Aug 17, 2023

Hereditary Angioedema, HAE Trial in United States (Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331)

Recruiting
  • Hereditary Angioedema
  • HAE
  • Dose 1 of BMN 331
  • +4 more
  • Birmingham, Alabama
  • +11 more
Jan 26, 2023

Hereditary Angioedema Trial in Worldwide (Donidalorsen, Placebo)

Recruiting
  • Hereditary Angioedema
  • Scottsdale, Arizona
  • +48 more
Jan 25, 2023

Hereditary Angioedema Trial in United States (Donidalorsen)

Recruiting
  • Hereditary Angioedema
  • Paradise Valley, Arizona
  • +19 more
Jan 23, 2023

Hereditary Angioedema Trial (STAR-0215)

Not yet recruiting
  • Hereditary Angioedema
  • (no location specified)
Jan 13, 2023

Hereditary Angioedema Trial in Adelaide (ADX-324, Placebo)

Recruiting
  • Hereditary Angioedema
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jan 10, 2023

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

Recruiting
  • Hereditary Angioedema
  • +11 more
  • PHA-022121 low dose
  • +3 more
  • Birmingham, Alabama
  • +7 more
Dec 5, 2022

Hereditary Angioedema Trial in Netherlands, United States (IONIS-PKK-LRx, Placebo)

Completed
Has Results
  • Hereditary Angioedema
  • Scottsdale, Arizona
  • +7 more
Sep 15, 2022

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)

Active, not recruiting
  • Hereditary Angioedema
  • +9 more
  • Birmingham, Alabama
  • +35 more
Aug 23, 2022

Hereditary Angioedema Trial (KVD900 600 mg)

Not yet recruiting
  • Hereditary Angioedema
  • KVD900 600 mg
  • (no location specified)
Aug 19, 2022

Hereditary Angioedema Trial (KVD900 600 mg)

Not yet recruiting
  • Hereditary Angioedema
  • KVD900 600 mg
  • (no location specified)
Aug 17, 2022

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)

Recruiting
  • Hereditary Angioedema
  • +9 more
  • Birmingham, Alabama
  • +21 more
Aug 11, 2022

Hereditary Angioedema Trial in West Bend (STAR-0215, Placebo)

Recruiting
  • Hereditary Angioedema
  • West Bend, Wisconsin
    Spaulding Clinical Research, LLC
Aug 9, 2022

Hereditary Angioedema Trial in Netherlands, United States (Donidalorsen)

Active, not recruiting
  • Hereditary Angioedema
  • Scottsdale, Arizona
  • +6 more
Aug 2, 2022

Hereditary Angioedema Trial in Worldwide (CSL312, Placebo)

Completed
  • Hereditary Angioedema
  • CSL312
  • Placebo
  • Birmingham, Alabama
  • +27 more
Aug 2, 2022

Hereditary Angioedema Trial in Worldwide (CSL312)

Active, not recruiting
  • Hereditary Angioedema
  • CSL312
  • Birmingham, Alabama
  • +43 more
Aug 2, 2022

Hereditary Angioedema Trial in Amsterdam, Auckland, Cambridge (Biological NTLA-2002, Normal Saline IV Administration)

Recruiting
  • Hereditary Angioedema
  • Biological NTLA-2002
  • Normal Saline IV Administration
  • Amsterdam, Netherlands
  • +2 more
Jul 18, 2022

Hereditary Angioedema, Pediatric Trial in Worldwide (Berotralstat)

Not yet recruiting
  • Hereditary Angioedema
  • Pediatric
  • Vienna, Austria
  • +15 more
Jul 8, 2022

Hereditary Angioedema Trial in Japan (TAK-743 300 mg)

Completed
  • Hereditary Angioedema
  • TAK-743 300 mg
  • Toyohashi, Aichi, Japan
  • +8 more
Jul 1, 2022

Hereditary Angioedema Trial in Canada, Puerto Rico, United States (Placebo, KVD900 600 mg, KVD900 300 mg)

Recruiting
  • Hereditary Angioedema
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +14 more
Jun 16, 2022

Burden of Illness and Treatment Patterns in Teenagers and

Recruiting
  • Hereditary Angioedema
    • Warszawa, Poland
    • +4 more
    May 6, 2022

    Hereditary Angioedema Trial in Nagakute, Bunkyo-ku, Kagoshima (TAK-667)

    Completed
    Has Results
    • Hereditary Angioedema
    • Nagakute, Aichi, Japan
    • +2 more
    Jan 25, 2022

    Biomarker for Hereditary AngioEdema Disease

    Completed
    • C1 Esterase Inhibitor Deficiency
    • +7 more
      • Yerevan, Armenia
      • +6 more
      Mar 23, 2022

      Hereditary Angioedema, HAE Trial in Worldwide (berotralstat)

      Active, not recruiting
      • Hereditary Angioedema
      • HAE
      • Brno, Czechia
      • +10 more
      Mar 2, 2022

      Hereditary Angioedema Kininogen Assay

      Terminated
      • Hereditary Angioedema
        • Berlin, Germany
        • +6 more
        Mar 9, 2022